Bioprinting reaches orbit
Auxilium Biotechnologies, a company headquartered in California, announced the successful fabrication of kidney and liver tissue aboard a spacecraft. The achievement was made possible by applying a 3‑D bioprinting technique that deposits living cells layer by layer in microgravity.
How the process works
The method uses a bio‑ink composed of viable cells mixed with a supportive matrix. While the technology has been validated in terrestrial laboratories, performing it in space introduces unique conditions that can affect cell behavior and tissue architecture.
Implications for space medicine
Being able to generate functional tissue off‑planet may support long‑duration missions by providing a potential source of transplant material and by improving understanding of how human cells adapt to the space environment, a key factor for astronaut health.
Future directions
Auxilium intends to refine the bioprinting system and expand testing to additional tissue types. The outcomes are expected to benefit not only space exploration but also regenerative medicine applications on Earth.